Physician profile
Naveen Kumar
NPI 1295729200
$1,896.64
in general payments reported to CMS, 2019-2025
21 companies · $13.92 in 2025
The $13.92 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $214 · 2021: $419 · 2022: $156 · 2023: $347 · 2024: $133 · 2025: $13.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $335.47 | 2019-2025 | Mounjaro, Jardiance |
| Novo Nordisk INC | $319.10 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Genentech USA, INC. | $245.28 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $202.83 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.02 | 2023 | Synjardy, Jardiance |
| Glaxosmithkline, LLC. | $124.00 | 2021 | |
| Abbvie INC. | $93.09 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $64.29 | 2019 | |
| Exact Sciences Corporation | $56.34 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $55.37 | 2020-2024 | Breztri, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $45.07 | 2019 | |
| Eisai INC. | $30.84 | 2020-2021 | |
| Almatica Pharma LLC | $23.68 | 2022 | |
| Mannkind Corporation | $22.99 | 2022 | |
| Itamar Medical INC | $22.37 | 2024 | Watchpatone |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $18.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.06 | 2023 | |
| Abbott Laboratories | $18.03 | 2022 | |
| Pfizer INC. | $16.57 | 2024 | |
| Idorsia Pharmaceuticals US INC | $16.14 | 2023 | Quviviq |
| Allergan, INC. | $13.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveen Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.